Metformin activates AMPK signal pathway, which not only decreases insulin resistance in type 2 diabetes mellitus but also blocks AMPK-mediated mTOR activation even in cancer stem cells (CSCs) [60]. The gene discussed is MTOR; the disease is diabetes mellitus.